Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection

New research highlights the need for heightened awareness and early testing for patients with signs of clotting disorder following vaccination

New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to them being treated successfully, highlighting the need for heightened awareness of the risk among doctors.